Evidence map›Paper›PMID 42630927›Full record

ArticleTH open : companion journal to thrombosis and haemostasis2026

PCSK9 Inhibitors Increase CD34+ But Not Other Endothelial Progenitor Cells in Patients with Chronic Coronary Disease and Increased Lp(a) Values.

Sabina Ugovšek, Andreja Rehberger Likozar, Tina Levstek, Katarina Trebušak Podkrajšek, Janja Zupan, Frieda Marka, Tamara Trimmel, Mira Brekalo, Walter S Speidl, Philipp J Hohensinner and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in TH open : companion journal to thrombosis and haemostasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sabina UgovšekFaculty of Medicine, University of LjubljanaLjubljanaLjubljanaSlovenia.ORCID 0000-0002-2056-4781
Andreja Rehberger LikozarDepartment of Vascular DiseasesUniversity Medical Centre LjubljanaLjubljanaLjubljanaSlovenia.
Tina LevstekLaboratory for Translational Medical BiochemistryInstitute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of LjubljanaLjubljanaLjubljanaSlovenia.
Katarina Trebušak PodkrajšekLaboratory for Translational Medical BiochemistryInstitute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of LjubljanaLjubljanaLjubljanaSlovenia.
Janja ZupanFaculty of Pharmacy, University of LjubljanaLjubljanaLjubljanaSlovenia.
Frieda MarkaDepartment of Internal Medicine IIMedical University of ViennaViennaViennaAustria.
Tamara TrimmelDepartment of Internal Medicine IIMedical University of ViennaViennaViennaAustria.
Mira BrekaloDepartment of Internal Medicine IIMedical University of ViennaViennaViennaAustria.
Walter S SpeidlDepartment of Internal Medicine IIMedical University of ViennaViennaViennaAustria.
Philipp J HohensinnerLudwig Boltzmann Cluster for Cardiovascular ResearchViennaViennaAustria.
Patrick HaiderDepartment of Internal Medicine IIMedical University of ViennaViennaViennaAustria.ORCID 0000-0001-6874-5349
Miran ŠebeštjenFaculty of Medicine, University of LjubljanaLjubljanaLjubljanaSlovenia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CD34 +endothelial functionendothelial progenitor cellslipoprotein(a)myocardial infarctionproprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors (PCSK9i)

Identifiers

PMID42630927
PMCPMC13494747

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.